Control
|
9
|
C-9 (100%), F-100%, T-100%
| |
AD
|
15
|
C-15 (100%), F-100%, T-100%
| |
PSP
|
3
|
C-0 (0%), F-0%, T-0%
|
1 assessor detected*
|
CBD/MAPT
|
7
|
C- 7 (100%), F-100%, T-100%
| |
DLB
|
5
|
C- 3 (60%), F-60%, T-40%
| |
MSA
|
3
|
C- 3 (100%), F-100%, T-100%
| |
HD
|
6
|
C- 5 (83%), F-83%, T-83%
|
1 assessor missed†
|
FTLD-TDP/FTLD-MND
|
6
|
C- 5 (83%), F-67%, T-83%
|
1-2 assessor(s) missed #
|
Metabolic disease
|
1
|
C-1 (100%), F-100%, T-100%
| |
Cerebrovascular disease
|
1
|
C-1 (100%), F-100%, T-100%
| |
ALS
|
2
|
C- 0 (0%), F-0%, T-0%
| |
Combined AD and DLB
|
4
|
C-3 (75%), F-75%, T-75%
|
1 assessor missed in limbic DLB case~
|